Search Results

Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens.

• Authors : DOHERTY, KYLE

Subjects: GYNECOLOGIC cancer; DRUG approval; CHEMORADIOTHERAPY

• Source: OncologyLive; Nov2024, Vol. 25 Issue 14, p16-19, 4p

Record details

Novel compound for CNV proves efficacious, safe in animal model.

• Authors : Greven, Craig M.; Meszaros, Liz

Subjects: UVEAL diseases; EYE blood-vessel diseases; OCUCURE Therapeutics Inc.

• Source: Ophthalmology Times. 4/15/2011, Vol. 36 Issue 8, p29-29. 1p.

Record details

Hello From Hawaii.

• Authors : Nagorka, Carrie; Bader, Kaitlyn

Subjects: ATOPIC dermatitis treatment; BALDNESS treatment; THERAPEUTIC use of monoclonal antibodies

• Source: Dermatology Times. Mar2023, Vol. 44 Issue 3, p30-33. 4p.

Record details

Emerging Treatment Options for the Management of Metastatic Castration-Resistant Prostate Cancer.

• Authors : GOMELLA, LEONARD

Subjects: PROSTATE tumors treatment; THERAPEUTIC use of antineoplastic agents; ANTIANDROGENS

• Source: Urology Times. Sep2021, Vol. 49 Issue 9, p33-35. 3p.

Record details

Drug Essentials Cabazitaxel, a Taxane for Men With Hormone-Refractory Metastatic Prostate Cancer.

• Authors : Wilkes, Gail M.

• Source: Oncology (08909091); Oct2010 Supplement, p46-48, 3p

Record details

Recent Advances in Antibody-Drug Conjugates for Lymphoma.

• Authors : Russler-Germain, David A.; Kahl, Brad S.

• Source: Oncology (08909091); Dec2020, Vol. 34 Issue 12, p522-534, 8p

Record details

Update on the Treatment of Heavily Pretreated, Relapsed Refractory Multiple Myeloma.

• Source: Oncology (08909091); Nov2020, Vol. 34 Issue 11, p504-507, 4p

Record details

CME Posttest.

Subjects: CANCER treatment; MALE reproductive organ cancer

• Source: Urology Times. 8/15/2006, Vol. 34 Issue 10, Special Section p14-14. 1p.

Record details

Mirvetuximab Soravtansine-gynx (Elahere): DECEMBER 5, 2023.

Subjects: THERAPEUTIC use of immunoglobulins; DRUG resistance in cancer cells; IMMUNOGLOBULINS

• Source: Targeted Therapies in Oncology; Feb2024, Vol. 13 Issue 2, p19-20, 2p

Record details

Eflornithine (Iwilfin): DECEMBER 13, 2023.

Subjects: THERAPEUTIC use of monoclonal antibodies; EFLORNITHINE; RISK assessmentUNITED StatesUNITED States. Food & Drug Administration

• Source: Targeted Therapies in Oncology; Feb2024, Vol. 13 Issue 2, p13-19, 2p

Record details